These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26220013)

  • 1. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
    Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
    Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study.
    Lee SR; Ahn HJ; Choi EK; Lee SW; Han KD; Oh S; Lip GYH
    Cardiovasc Diabetol; 2023 Jan; 22(1):18. PubMed ID: 36717853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
    Bansilal S; Bloomgarden Z; Halperin JL; Hellkamp AS; Lokhnygina Y; Patel MR; Becker RC; Breithardt G; Hacke W; Hankey GJ; Nessel CC; Singer DE; Berkowitz SD; Piccini JP; Mahaffey KW; Fox KA;
    Am Heart J; 2015 Oct; 170(4):675-682.e8. PubMed ID: 26386791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinical characteristics and risk of stroke and death within 1 year of patients with nonvalvular atrial fibrillation combined with diabetes mellitus].
    Wu S; Yang YM; Zhu J; Huang B; Wang J; Wan HB; Zhang H; Shao XH
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2044-8. PubMed ID: 27468614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
    Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.
    van Doorn S; Tavenier A; Rutten FH; Hoes AW; Moons KGM; Geersing GJ
    BMJ Open; 2018 Aug; 8(8):e021681. PubMed ID: 30139900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    Echouffo-Tcheugui JB; Shrader P; Thomas L; Gersh BJ; Kowey PR; Mahaffey KW; Singer DE; Hylek EM; Go AS; Peterson ED; Piccini JP; Fonarow GC
    J Am Coll Cardiol; 2017 Sep; 70(11):1325-1335. PubMed ID: 28882229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
    Al-Khalili F; Benson L; Friberg L
    Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.
    Lai HC; Chien WC; Chung CH; Lee WL; Wu TJ; Wang KY; Liu CN; Liu TJ
    Eur J Intern Med; 2015 Dec; 26(10):798-806. PubMed ID: 26493861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.